anti-trypanosomal drugs (GSK)

N/A

Report date: 2025/01/26 18:26:45
NME

Base Information

Drug Nameanti-trypanosomal drugs (GSK)
Drug Alias Nameanti-trypanosomal drugs (GlaxoSmithKline)SR-037
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChagas DiseaseLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsChagas DiseaseLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A